oxycodone has been researched along with Cognitive Dysfunction in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
de Guglielmo, G; Fu, Y; Giorgi, FM; Kim, HR; Lefebvre, C; Lorrai, I; Marquez Gaytan, J; Mercatelli, D; Repunte-Canonigo, V; Sanna, PP; Shankula, C; Sumazin, P; Zorman, B | 1 |
Box, JG; Foster, M; Jackson, D; Mahdi, F; Paris, JJ; Qrareya, AN; Salahuddin, MF; Vujanovic, T | 1 |
Bundrick, JB; Litin, SC; Tung, EE | 1 |
3 other study(ies) available for oxycodone and Cognitive Dysfunction
Article | Year |
---|---|
Escalated (Dependent) Oxycodone Self-Administration Is Associated with Cognitive Impairment and Transcriptional Evidence of Neurodegeneration in Human Immunodeficiency Virus (HIV) Transgenic Rats.
Topics: Analgesics, Opioid; Animals; Cognitive Dysfunction; Glucocorticoids; HIV; HIV Infections; Humans; Oxycodone; Rats; Rats, Transgenic | 2022 |
Combined HIV-1 Tat and oxycodone activate the hypothalamic-pituitary-adrenal and -gonadal axes and promote psychomotor, affective, and cognitive dysfunction in female mice.
Topics: Animals; Anxiety; Cognitive Dysfunction; Drug Combinations; Female; Gonadal Steroid Hormones; Gonads; HIV Infections; HIV-1; Humans; Hypothalamo-Hypophyseal System; Mice; Mice, Transgenic; Mood Disorders; Neurotoxicity Syndromes; Oxycodone; Pituitary-Adrenal System; Psychomotor Disorders; tat Gene Products, Human Immunodeficiency Virus; Tumor Cells, Cultured | 2020 |
Clinical Pearls in Geriatrics.
Topics: Acetaminophen; Aged; Aged, 80 and over; Automobile Driving; Cognition Disorders; Cognitive Dysfunction; Colonic Neoplasms; Delirium; Dementia; Donepezil; Early Detection of Cancer; Estrogen Replacement Therapy; Female; Geriatrics; Humans; Indans; Male; Neuropsychological Tests; Nootropic Agents; Oxycodone; Piperidines; Urinary Incontinence; Watchful Waiting | 2017 |